Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globant S.A. stock logo
GLOB
Globant
$38.98
+14.4%
$44.57
$32.50
$107.12
$1.71B1.041.61 million shs6.51 million shs
NiCE stock logo
NICE
NiCE
$89.76
+2.1%
$107.78
$84.38
$180.61
$5.42B0.82812,898 shs677,327 shs
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.35
-3.8%
$46.66
$27.07
$51.63
$5.91B0.71.31 million shs1.35 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globant S.A. stock logo
GLOB
Globant
0.00%-0.59%-21.04%-21.17%-70.66%
NiCE stock logo
NICE
NiCE
0.00%-3.20%-14.55%-13.32%-47.03%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
0.00%+1.98%-1.30%+7.33%+61.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globant S.A. stock logo
GLOB
Globant
$38.98
+14.4%
$44.57
$32.50
$107.12
$1.71B1.041.61 million shs6.51 million shs
NiCE stock logo
NICE
NiCE
$89.76
+2.1%
$107.78
$84.38
$180.61
$5.42B0.82812,898 shs677,327 shs
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$49.35
-3.8%
$46.66
$27.07
$51.63
$5.91B0.71.31 million shs1.35 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globant S.A. stock logo
GLOB
Globant
0.00%-0.59%-21.04%-21.17%-70.66%
NiCE stock logo
NICE
NiCE
0.00%-3.20%-14.55%-13.32%-47.03%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
0.00%+1.98%-1.30%+7.33%+61.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globant S.A. stock logo
GLOB
Globant
2.39
Hold$64.8166.28% Upside
NiCE stock logo
NICE
NiCE
2.36
Hold$136.9252.54% Upside
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
3.17
Buy$56.0013.48% Upside

Current Analyst Ratings Breakdown

Latest SRRK, GLOB, and NICE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Set Price Target$54.00
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Lower Price TargetPositive$90.00 ➝ $78.00
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Lower Price TargetNeutral$68.00 ➝ $60.00
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Lower Price TargetHold$50.00 ➝ $40.00
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Lower Price TargetHold$54.00 ➝ $44.00
5/15/2026
Globant S.A. stock logo
GLOB
Globant
Lower Price TargetBuy$60.00 ➝ $50.00
5/11/2026
NiCE stock logo
NICE
NiCE
Lower Price TargetOverweight$148.00 ➝ $130.00
5/8/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
Boost Price TargetOverweight$53.00 ➝ $55.00
5/8/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
Boost Price TargetBuy$58.00 ➝ $65.00
5/8/2026
NiCE stock logo
NICE
NiCE
Lower Price TargetNeutral$119.00 ➝ $100.00
5/7/2026
NiCE stock logo
NICE
NiCE
Lower Price TargetOutperform$150.00 ➝ $130.00
(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globant S.A. stock logo
GLOB
Globant
$2.45B0.70$9.21 per share4.23$49.10 per share0.79
NiCE stock logo
NICE
NiCE
$2.95B1.84$14.60 per share6.15$60.84 per share1.48
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
N/AN/AN/AN/A$2.30 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globant S.A. stock logo
GLOB
Globant
$102.92M$2.4615.847.151.434.46%9.86%6.46%N/A
NiCE stock logo
NICE
NiCE
$612.10M$8.4310.658.720.9317.57%17.42%12.83%N/A
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
-$377.94M-$3.59N/AN/AN/AN/A-163.52%-96.67%8/5/2026 (Estimated)

Latest SRRK, GLOB, and NICE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Globant S.A. stock logo
GLOB
Globant
$1.50$1.50N/A$0.85$601.66 million$607.09 million
5/7/2026Q1 2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
-$0.82-$0.83-$0.01-$0.83$5.00 millionN/A
5/6/2026Q1 2026
NiCE stock logo
NICE
NiCE
$2.52$2.64+$0.12$0.77$760.94 million$768.62 million
3/3/2026Q4 2025
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
-$0.86-$0.76+$0.10-$0.76N/AN/A
2/26/2026Q4 2025
Globant S.A. stock logo
GLOB
Globant
$1.54$1.54N/A$0.93$605.61 million$612.47 million
2/19/2026Q4 2025
NiCE stock logo
NICE
NiCE
$3.23$3.24+$0.01$2.41$779.95 million$786.50 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Globant S.A. stock logo
GLOB
Globant
N/AN/AN/AN/AN/A
NiCE stock logo
NICE
NiCE
N/AN/AN/AN/AN/A
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globant S.A. stock logo
GLOB
Globant
0.16
1.64
1.64
NiCE stock logo
NICE
NiCE
N/A
1.22
1.22
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
0.71
8.64
6.95

Institutional Ownership

CompanyInstitutional Ownership
Globant S.A. stock logo
GLOB
Globant
91.60%
NiCE stock logo
NICE
NiCE
63.34%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
91.08%

Insider Ownership

CompanyInsider Ownership
Globant S.A. stock logo
GLOB
Globant
2.67%
NiCE stock logo
NICE
NiCE
0.02%
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
13.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globant S.A. stock logo
GLOB
Globant
28,77343.84 million42.67 millionOptionable
NiCE stock logo
NICE
NiCE
9,62660.43 million60.42 millionOptionable
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
140119.83 million103.89 millionOptionable

Recent News About These Companies

Barclays Remains a Buy on Scholar Rock Holding (SRRK)
HC Wainwright Predicts Stronger Earnings for Scholar Rock
Scholar Rock (SRRK) Q1 2026 Earnings Transcript
Scholar Rock Q1 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Globant stock logo

Globant NYSE:GLOB

$38.98 +4.90 (+14.37%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$38.55 -0.43 (-1.10%)
As of 05/15/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globant S.A., together with its subsidiaries, provides technology services worldwide. It provides digital solutions comprising blockchain, cloud technologies, cybersecurity, data and artificial intelligence, digital experience and performance, code, Internet of Things, metaverse, and engineering and testing; and enterprise technology solutions and services, such as Agile organization, Cultural Hacking, process optimization services, as well as AWS, Google Cloud, Microsoft, Oracle, SalesForce, SAP, and ServiceNow technology solutions. Further, the company provides e-commerce, conversational interfaces, design, digital marketing, and digital product delivery services. Additionally, it operates Augoor, an AI-powered platform; MagnifAI, an AI-powered solution for software quality assurance; StarMeUp, a science-based AI platform; WaaSabi, a finance platform; Walmeric, a lead-to-revenue management platform; GeneXus, a suit of AI development tools; Navigate for process optimization powerhouse; BeHealthy, a white-label platform; and FluentLab, an AI conversational and engagement solution. The company offers its services to various industries, including media and entertainment, professional services, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail and manufacturing, health care, and others. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.

NiCE stock logo

NiCE NASDAQ:NICE

$89.76 +1.82 (+2.07%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$89.84 +0.08 (+0.09%)
As of 05/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NiCE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self-service enables organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real-time AI-based routing. The company provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time; provides solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NiCE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NiCE-Systems Ltd. and changed its name to NiCE Ltd. in June 2016. NiCE Ltd. was founded in 1986 and is headquartered in Ra'anana, Israel.

Scholar Rock stock logo

Scholar Rock NASDAQ:SRRK

$49.35 -1.93 (-3.76%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$49.34 -0.01 (-0.01%)
As of 05/15/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.